HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ChromaDex Corp.


Latest From ChromaDex Corp.

Nestlé Grows Health Offering With Global Deal for Anti-Aging Supplement

In line with its nutrition, health and wellness strategy, Nestlé has bolstered its consumer health offering with ChromaDex’ innovative energy boosting supplement.

Deals Dietary Supplements

Health, Beauty And Wellness News: Nutrisystem Adds Options, Roar Gains $5.6M, SynTech Elite In US, More News

Nurtisystem launches FreshStart, South Beach Keto; Roar Beverage $5.6m funding led by AccelFoods; SynTech brings Elite Series to US; ChromaDex extends Tru Niagen to Canada with Fullscript; Nugenix Sexual Vitality Booster with Nitrosigine; Abattis debuts Vergence Naturals with Comfort; Brueggman takes Vitaquest helm; and CBD Bath Soaks from allitom.

Wellness Dietary Supplements

Deals Shaping The Medical Industry, December 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance or Financing. This month’s column covers deals announced in November 2017.

Deals BioPharmaceutical

Ad Claims, Q3 Results, Private Placement: Health & Wellness Industry News

NAD tips Balance of Nature claim to FTC; Vitamin Shoppe sales down 8.5%; ChromaDex gains $23m in private placement; and more health and wellness news in brief.

Dietary Supplements Consumer
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ChromaDex Corp.
  • Senior Management
  • Frank, Jr. Jaksch, CEO
    Kevin Farr, CFO
    Claire L Kruger, PhD, Consulting President
    Troy Rhonemus, COO
    Aron Erickson, Dir. Tech.
    Robert Fried, President, CSO
    Tom Varvano, SVP, Finance
    Lisa Bratkovich, Chief Mktg. Officer
  • Contact Info
  • ChromaDex Corp.
    Phone: (949) 419-0288
    10005 Muirlands Blvd.
    Ste. G, 1st Fl.
    Irvine, CA 92618